The purpose of this study is to examine the acute effects of cannabigerol (CBG) on various psychological (e.g., anxiety, stress, mood, memory, impairment, intoxication, side effects) and physiological (blood pressure, cortisol, heart rate variability, electrodermal activity, pain tolerance, temperature) outcomes. Further, potential side effects of CBG (sleepiness/fatigue, dry mouth/eyes, increased appetite, and dizziness nausea) will be assessed. As such, the study is focused on better understanding some of the potentially beneficial and detrimental effects of CBG on humans.
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Anxiety
Timeframe: Anxiety ratings will occur within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart
Stress
Timeframe: Stress ratings will occur within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart
Mood
Timeframe: Mood ratings will occur within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart
Salivary Cortisol
Timeframe: Saliva samples will be collected within the 2.5 hour time frame for each session with sessions scheduled approximately one week apart
Electrodermal Activity
Timeframe: Electrodermal Activity will be measured continuously for the duration of the 2.5 hour session for each session with sessions scheduled approximately one week apart
Heart Rate/Heart Rate Variability
Timeframe: Heart Rate/Heart Rate Variability will be assessed continuously for the duration of the 2.5 hour session with sessions scheduled approximately one week apart
Blood Pressure
Timeframe: Blood Pressure will be obtained multiple times throughout the 2.5 hour session for each session with sessions scheduled approximately one week apart
Pain Tolerance
Timeframe: Pain tolerance will be assessed within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart
Verbal Memory
Timeframe: Participants will complete this test within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart
Short-Term/Working Memory
Timeframe: Participants will complete this test within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart
False Memory
Timeframe: Participants will complete this test within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart